SCHEMBL29429270

SCHEMBL29429270

CCCCCCCCCCCCCCCCCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ SLC6A5 Q9Y345 2/20 0.47
▸ FAAH O00519 7/20 0.44
▸ ITGB3 P05106 3/20 0.43
▸ ITGA2B P08514 3/20 0.43
▸ NOD1 Q9Y239 3/20 0.43
▸ MEN1 O00255 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ ALDH1A1 P00352 2/20 0.39
▸ ASAH1 Q13510 1/20 0.39
▸ ACER2 Q5QJU3 1/20 0.39
▸ PSMB5 P28074 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29429271 1.00 SLC6A5 (0.47) SLC6A5FAAHITGB3ITGA2BNOD1
SCHEMBL16432430 1.00 SLC6A5 (0.47) SLC6A5FAAHITGB3ITGA2BNOD1
SCHEMBL16432431 1.00 SLC6A5 (0.47) SLC6A5FAAHITGB3ITGA2BNOD1
SCHEMBL29429319 1.00 SLC6A5 (0.47) SLC6A5FAAHITGB3ITGA2BNOD1
SCHEMBL29674934 0.93 SLC6A5 (0.43) SLC6A5FAAHITGB3ITGA2BNOD1
SCHEMBL29429288 0.93 SLC6A5 (0.43) SLC6A5FAAHITGB3ITGA2BNOD1
SCHEMBL30781162 0.91 SLC6A5 (0.37) SLC6A5FAAHITGB3ITGA2B
SCHEMBL4348856 0.91 SLC6A5 (0.54) SLC6A5FAAHITGB3ITGA2BNOD1
SCHEMBL19138237 0.91 SLC6A5 (0.54) SLC6A5FAAHITGB3ITGA2BNOD1
SCHEMBL19138218 0.91 SLC6A5 (0.54) SLC6A5FAAHITGB3ITGA2BNOD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114846108-B Anti-pollution material 日产化学株式会社 2024-08-20 — — CN disclosed
US-20240116979-A1 METHOD FOR PRODUCING LIPIDIC PEPTIDE NISSAN CHEMICAL CORPORATION (JP) 2024-04-11 — — US disclosed
US-20240067675-A1 METHOD FOR PRODUCING LIPID PEPTIDE NISSAN CHEMICAL CORPORATION (JP) 2024-02-29 — — US disclosed
US-20230404888-A1 COMPOSITION CONTAINING LIPID PEPTIDE AND SUCROSE ESTER NISSAN CHEMICAL CORPORATION (JP) 2023-12-21 — — US disclosed
EP-4265629-A1 METHOD FOR PRODUCING LIPID PEPTIDE Nissan Chemical Corporation (JP) 2023-10-25 — — EP disclosed
US-11771645-B2 Transdermally absorbable base material containing lipid peptide compound KYUSHU UNIVERSITY (JP) 2023-10-03 — — US disclosed
CN-116744892-A Compositions comprising a lipid peptide and a sucrose ester 日产化学株式会社 2023-09-12 — — CN disclosed
CN-116648455-A Method for preparing lipid peptide 日产化学株式会社 2023-08-25 — — CN disclosed
EP-4230265-A1 COMPOSITION CONTAINING LIPID PEPTIDE AND SUCROSE ESTER Nissan Chemical Corporation (JP) 2023-08-23 — — EP disclosed
CN-116615435-A Method for preparing lipid peptide 日产化学株式会社 2023-08-18 — — CN disclosed
EP-3881823-B1 SOLID BASE MATERIAL CONTAINING LIPID PEPTIDE COMPOUND NISSAN CHEMICAL CORP (JP) 2023-01-25 — — EP disclosed
EP-4074380-A1 ANTI-POLLUTION MATERIAL Nissan Chemical Corporation (JP) 2022-10-19 — — EP disclosed
US-11452688-B2 Transdermally absorbable base material containing lipid peptide compound KYUSHU UNIVERSITY (JP) 2022-09-27 — — US disclosed
WO-2022168894-A1 CLOTH OR PAPER ANTI-POLLUTION MATERIAL 日産化学株式会社 2022-08-11 — — WO disclosed
CN-114846108-A Anti-pollution material 日产化学株式会社 2022-08-02 — — CN disclosed
WO-2022138957-A1 METHOD FOR PRODUCING LIPIDIC PEPTIDE 日産化学株式会社 2022-06-30 — — WO disclosed
WO-2022138953-A1 METHOD FOR PRODUCING LIPID PEPTIDE 日産化学株式会社 2022-06-30 — — WO disclosed
EP-4014958-A1 COATING FILM-FORMING COMPOSITION Nissan Chemical Corporation (JP) 2022-06-22 — — EP disclosed
WO-2022092284-A1 COMPOSITION CONTAINING LIPID PEPTIDE AND SUCROSE ESTER 日産化学株式会社 2022-05-05 — — WO disclosed
WO-2022065433-A1 COSMETIC FOR HAIR 日産化学株式会社 2022-03-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230404888-A1 COMPOSITION CONTAINING LIPID PEPTIDE AND SUCROSE ESTER CUTA, SCAMP3, SURF4 SLC6A5 1995/4885FAAH 1817/4885ITGB3 2557/4885
US-20240067675-A1 METHOD FOR PRODUCING LIPID PEPTIDE VIP, NGLY1, NPPA SLC6A5 1803/4885FAAH 288/4885ITGB3 1694/4885
US-20240116979-A1 METHOD FOR PRODUCING LIPIDIC PEPTIDE NPPA, VIP, NGLY1 SLC6A5 1172/4885FAAH 329/4885ITGB3 4464/4885
US-11771645-B2 Transdermally absorbable base material containing lipid peptide compound NGLY1, NR1H4, HRH1 SLC6A5 1157/4885FAAH 8/4885ITGB3 3315/4885
US-11452688-B2 Transdermally absorbable base material containing lipid peptide compound NGLY1, NR1H4, HRH1 SLC6A5 1157/4885FAAH 8/4885ITGB3 3315/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback